
<tr>
  <td width="600" style="width: 600px">
    <table width="600" cellpadding="0" cellspacing="0" border="0" valign="top" style="width: 600px;min-width: 600px; vertical-align: middle; background-color: transparent; xxxxxxline-height: 18px;">
      <tr>
        <td width="35" style="width: 35px;"></td>
        <td width="530" style="width: 530px; color: #636363; font-family: Arial, sans-serif; font-weight: bold; font-size: 18px;">
          Considering Levemir<sup style="font-size:0.6em; line-height:0; vertical-align:5px;-webkit-text-size-adjust:none;">&reg;</sup>? Choose Tresiba<sup style="font-size:0.6em; line-height:0; vertical-align:5px;-webkit-text-size-adjust:none;">&reg;</sup>        </td>
        <td width="35" style="width: 35px;"></td>
      </tr>
    </table>
    <table width="600" cellpadding="0" cellspacing="0" border="0" valign="top" style="width: 600px;min-width: 600px; vertical-align: middle; background-color: transparent; line-height: 18px;">
      <tr>
        <td width="180" valign="top" style="width: 180px; line-height: 0px; padding-top: 10px; vertical-align: top;">
          <img src="https://cdnae1.vod309.com/4abc42fa-0fdf-4c78-8704-da625c7d5356/0000000/000000/001/155/7/2/assetFiles/images/images/divider.png" style="display: block;" />
        </td>
      </tr>
    </table>
    <table width="600" cellpadding="0" cellspacing="0" border="0" valign="top" style="width: 600px;min-width: 600px; vertical-align: middle; background-color: transparent;">
      <tr>
        <td width="35" style="width: 35px;"></td>
        <td width="530" style="width: 530px; padding-top: 15px; padding-bottom: 15px; color: #434343; font-family: Arial, sans-serif; font-size: 14px; line-height: 18px;">
          As you know, there is another U-100 option from Novo Nordisk with added features. Starting patients on Tresiba<sup style="font-size:0.7em; line-height:0; vertical-align:4px;-webkit-text-size-adjust:none;">&reg;</sup> is similar to starting patients on Levemir<sup style="font-size:0.7em; line-height:0; vertical-align:4px;-webkit-text-size-adjust:none;">&reg;</sup>. Both options&nbsp;have the same concentration, a similar starting dose, and are administered using the FlexTouch<sup style="font-size:0.7em; line-height:0; vertical-align:4px;-webkit-text-size-adjust:none;">&reg;</sup> device.(2,3,a) However, clinical data show that Tresiba<sup style="font-size:0.7em; line-height:0; vertical-align:4px;-webkit-text-size-adjust:none;">&reg;</sup> has <strong>even more to offer</strong>. And, out-of-pocket costs may be lower for Tresiba<sup style="font-size:0.7em; line-height:0; vertical-align:4px;-webkit-text-size-adjust:none;">&reg;</sup>.
        </td>
        <td width="35" style="width: 35px;"></td>
      </tr>
      <tr>
        <td width="35" style="width: 35px;"></td>
        <td width="206" style="width: 206px; line-height: 0px;">
          <a href="https://www.tresibapro.com/dosing-and-device/starting-adult-patients.html?utm_source=veeva_closerlook&utm_medium=email&utm_content=Tresiba_Levemir_Conversion&utm_campaign=tresiba%202018_levconv" target="_blank" style="border: none; text-decoration: none; display: block;">
            <img src="https://cdnae1.vod309.com/4abc42fa-0fdf-4c78-8704-da625c7d5356/0000000/000000/001/155/7/2/assetFiles/images/images/button-choose.png" alt="Choose TresibaÂ®" style="display: block;" />
          </a>
        </td>
        <td width="35" style="width: 35px;"></td>
      </tr>
      <tr>
        <td width="35" style="width: 35px;"></td>
        <td width="530" style="width: 530px; padding-top: 20px; padding-bottom: 3px; color: #434343; font-family: Arial, sans-serif; font-size: 14px; line-height: 18px;">
          (a)Tresiba<sup style="font-size:0.7em; line-height:0; vertical-align:4px;-webkit-text-size-adjust:none;">&reg;</sup> is also available in a U-200 concentration. 
        </td>
        <td width="35" style="width: 35px;"></td>
      </tr>
    </table>
  </td>
</tr>